ABT

Abbott Laboratories
Data: 2026-05-14
$84.9
Price
1.28%
Change
$139.06
52W High
$81.97
52W Low

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Quick Stats
May 14, 2026

53.4

AI Score

HOLD

0.85

Volume Ratio

Jul 16, 2026

Next Earnings

12

+ve Days (30d)

18

-ve Days (30d)

ABT Stock Summary

Last updated May 14, 2026

ABT is currently trading at $84.9, positioned below its 200-day moving average of $118.76, suggesting bearish momentum. The stock has a 52-week range of $81.97 to $139.06.

Technical Analysis: The 50-day moving average stands at $98.81, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 31.377, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.208, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ABT at 53.4/100 with a HOLD recommendation.

ABT (Abbott Laboratories) Indicators

Last updated May 14, 2026

Indicator Value
RSI(14) 31.377
CMF (20) -0.208
ROC (10) -6.487
ADX (14) 54.181
Indicator Value
MACD (12,26,9) -4.427
AROONOSC (14) -64.286
WILLAMS %R (14) -77.145
MFI (14) 35.273
ABT Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ABT Price vs Max Options Open Interest
ABT Max Change In Options Open Interest

ABT Options - Sort by Max open Interest (near term)

14th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABT Daily Out of Money Options - Sort by Max open Interest (near term)

14th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABT Daily In the Money Options - Sort by Max open Interest (near term)

14th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

ABT Most Active Options by Volume(near term)

14th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Abbott Laboratories is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

ABT Moving Averages Analysis

ABT (Abbott Laboratories) Simple Moving Averages

Moving Averages are last updated May 14, 2026

Days MA
10 85.74
20 89.35
30 93.31
50 98.81
100 107.9
200 118.76

ABT Fundamental Analysis

P/E (Forward) 15.4083
P/E (Trailing) 23.4818
Market Cap ($) 146.0 billion
Earnings/Share ($) 3.57
Net Proft Margin (%) 0.139
Dividend/Share ($) 2.44
EPS Estimate Current Year ($) 5.4829
EPS Estimate Next Year ($) 6.064
WallStreet Target Price ($) 118.64
Most Recent Quarter